Takahiro Kogawa

Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer

T. Fujii, Takahiro Kogawa, Wanli Dong et al. · Annals of Oncology · 2017 · 161 citations · Full text

Medicine, Endocrinology, Oncology +11

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study

Aditya Bardia, Ian E. Krop, Takahiro Kogawa et al. · Journal of Clinical Oncology · 2024 · 159 citations · Full text

Medicine, Oncology, Pharmacology +17

c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun

Xuemei Xie, Tamer S. Kaoud, Ramakrishna Edupuganti et al. · Oncogene · 2016 · 103 citations · Full text

Medicine, Cell Biology, Oncology +16

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis

Tamer M. Fouad, Takahiro Kogawa, Diane D. Liu et al. · Breast Cancer Research and Treatment · 2015 · 95 citations · Full text

Medicine, Oncology, Surgery +16

A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors

Hirofumi Mukai, Takahiro Kogawa, Nobuaki Matsubara et al. · Investigational New Drugs · 2017 · 82 citations

Medicine, Oncology, Pharmacology +16